UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.229

Sortiert nach

Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients

Journal of viral hepatitis, 2016-01, Vol.23 (1), p.47-52

2016

Link zum Volltext

Verfügbarkeit prüfen

Oral antivirals for the prevention and treatment of SARS-CoV-2 infection

AIDS reviews, 2022-03, Vol.24 (1), p.41-49

2022

Link zum Volltext

Verfügbarkeit prüfen

Commentary on Bretana et al. (2020): Prevention and treatment in the prison setting will be key to achieving HCV elimination

Addiction (Abingdon, England), 2020-05, Vol.115 (5), p.915-916

2020

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of prolonged tenofovir therapy on hepatitis delta in HIV-infected patients

AIDS (London), 2014-10, Vol.28 (16), p.2389-2394

2014

Link zum Volltext

Verfügbarkeit prüfen

New SARS-CoV-2 Variants Challenge Vaccines Protection

AIDS reviews, 2021-01, Vol.23 (1), p.57-58

2021

Link zum Volltext

Verfügbarkeit prüfen

Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain

Liver international, 2013-10, Vol.33 (9), p.1357-1362

2013

Link zum Volltext

Verfügbarkeit prüfen

Assessment of the binder blending in bituminous mixtures based on the development of an innovative sustainable infrared imaging methodology

Journal of cleaner production, 2019-04, Vol.215, p.821-828

2019

Link zum Volltext

Verfügbarkeit prüfen

Prevention and management of treatment failure to new oral hepatitis C drugs

Expert opinion on pharmacotherapy, 2016-06, Vol.17 (9), p.1215-1223

2016

Link zum Volltext

Verfügbarkeit prüfen

Rebound in sexually transmitted infections after the COVID-19 pandemic

AIDS reviews, 2023-07, Vol.25 (3), p.127-135

2023

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C Therapy: Highlights From the 2012 Annual Meeting of the European Association for the Study of the Liver

Clinical infectious diseases, 2013-02, Vol.56 (4), p.560-566

2013

Link zum Volltext

Verfügbarkeit prüfen

Advances in hepatitis B therapeutics

Therapeutic Advances in Infectious Disease, 2020, Vol.7, p.204993612096502

2020

Link zum Volltext

Verfügbarkeit prüfen

Drug interactions with new hepatitis C oral drugs

Expert opinion on drug metabolism & toxicology, 2015-03, Vol.11 (3), p.333-341

2015

Link zum Volltext

Verfügbarkeit prüfen

Experimental investigation of blending phenomena in intergranular zones of recycled asphalt mixtures using customized infrared imaging and stage extraction methods

Construction & building materials, 2019-07, Vol.213, p.234-245

2019

Link zum Volltext

Verfügbarkeit prüfen

Towards a better understanding of wetting regimes at the interface asphalt/aggregate during warm-mix process of asphalt mixtures

Construction & building materials, 2017-02, Vol.133, p.182-195

2017

Link zum Volltext

Verfügbarkeit prüfen

Study of remobilization phenomena at reclaimed asphalt binder/virgin binder interphases for recycled asphalt mixtures using novel microscopic methodologies

Construction & building materials, 2018-03, Vol.165, p.846-858

2018

Link zum Volltext

Verfügbarkeit prüfen

Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals

AIDS reviews, 2023-10, Vol.25 (4), p.162

2023

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C Cure with Antiviral Therapy – Benefits beyond the Liver

Antiviral Therapy, 2016-01, Vol.21 (1), p.1-8

2016

Link zum Volltext

Verfügbarkeit prüfen

Long-term survival and liver-related events after pegylated interferon/ribavirin therapy in HIV-infected patients with chronic hepatitis C

Antiviral therapy, 2015, Vol.20 (1), p.65-72

2015

Link zum Volltext

Verfügbarkeit prüfen

Treatment of hepatitis C with new fixed dose combinations

Expert opinion on pharmacotherapy, 2017-08, Vol.18 (12), p.1235-1242

2017

Link zum Volltext

Verfügbarkeit prüfen

The changing face of hepatitis C in the new era of direct-acting antivirals

Antiviral research, 2013-01, Vol.97 (1), p.36-40

2013

Link zum Volltext

Verfügbarkeit prüfen

NEURAL MECHANISMS OF DIFFERENCES IN MICTURITION-RELATED BRAIN ACTIVITY OF STROKE SURVIVORS WITH LOWER URINARY TRACT DYSFUNCTION: A BRAIN-BLADDER STUDY COMPARING BASAL GANGLIA AND PONTINE LESIONS

Continence (Amsterdam), 2023-09, Vol.7, p.100761, Article 100761

2023

Link zum Volltext

Verfügbarkeit prüfen

Drug interactions in HIV-infected patients treated for hepatitis C

Expert opinion on drug metabolism & toxicology, 2017-08, Vol.13 (8), p.807-816

2017

Link zum Volltext

Verfügbarkeit prüfen

New hepatitis C therapies for special patient populations

Expert opinion on pharmacotherapy, 2016-01, Vol.17 (2), p.217-229

2016

Link zum Volltext

Verfügbarkeit prüfen

AIDS Clinical Research in Spain-Large HIV Population, Geniality of Doctors, and Missing Opportunities

Viruses, 2018-05, Vol.10 (6), p.293

2018

Link zum Volltext

Verfügbarkeit prüfen

Rate and predictors of serum HCV-RNA >6 million IU/mL in patients with chronic hepatitis C

Journal of clinical virology, 2015-10, Vol.71, p.63-66

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.229

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.859)
Mit Volltextzugriff
(1.926)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.151)
Life Sciences & Biomedicine
(768)
Humans
(633)
Female
(361)
Male
(360)
Physical Sciences
(338)
Middle Aged
(242)
Biological And Medical Sciences
(232)
Adult
(204)
Physics
(184)
Aged
(169)
Technology
(169)
Animals
(159)
Exact Sciences And Technology
(131)
Medical Sciences
(124)
Fundamental And Applied Biological Sciences. Psychology
(118)
Astronomy & Astrophysics
(113)
Infectious Diseases
(96)
Spain
(91)
Risk Factors
(79)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(18)
... seit 30 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients

Oral antivirals for the prevention and treatment of SARS-CoV-2 infection

Commentary on Bretana et al. (2020): Prevention and treatment in the prison setting will be key to achieving HCV elimination

Efficacy of prolonged tenofovir therapy on hepatitis delta in HIV-infected patients

New SARS-CoV-2 Variants Challenge Vaccines Protection

Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain

Assessment of the binder blending in bituminous mixtures based on the development of an innovative sustainable infrared imaging methodology

Prevention and management of treatment failure to new oral hepatitis C drugs

Rebound in sexually transmitted infections after the COVID-19 pandemic

Hepatitis C Therapy: Highlights From the 2012 Annual Meeting of the European Association for the Study of the Liver

Advances in hepatitis B therapeutics

Drug interactions with new hepatitis C oral drugs

Experimental investigation of blending phenomena in intergranular zones of recycled asphalt mixtures using customized infrared imaging and stage extraction methods

Towards a better understanding of wetting regimes at the interface asphalt/aggregate during warm-mix process of asphalt mixtures

Study of remobilization phenomena at reclaimed asphalt binder/virgin binder interphases for recycled asphalt mixtures using novel microscopic methodologies

Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals

Hepatitis C Cure with Antiviral Therapy – Benefits beyond the Liver

Long-term survival and liver-related events after pegylated interferon/ribavirin therapy in HIV-infected patients with chronic hepatitis C

Treatment of hepatitis C with new fixed dose combinations

The changing face of hepatitis C in the new era of direct-acting antivirals

NEURAL MECHANISMS OF DIFFERENCES IN MICTURITION-RELATED BRAIN ACTIVITY OF STROKE SURVIVORS WITH LOWER URINARY TRACT DYSFUNCTION: A BRAIN-BLADDER STUDY COMPARING BASAL GANGLIA AND PONTINE LESIONS

Drug interactions in HIV-infected patients treated for hepatitis C

New hepatitis C therapies for special patient populations

AIDS Clinical Research in Spain-Large HIV Population, Geniality of Doctors, and Missing Opportunities

Rate and predictors of serum HCV-RNA >6 million IU/mL in patients with chronic hepatitis C

Suchergebnisse filtern